PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Phio Pharmaceuticals Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.87−0.00 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $10.09M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2024(first seen in filings) | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Jul 5, 2024 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Mar 22, 2023(first seen in filings) | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Jan 26, 2023 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Jan 15, 2020 | 1-for-55 reverse | Earlier per-share figures multiplied by 55 |
| Jan 15, 2020 | 1-for-55 reverse | Earlier per-share figures multiplied by 55 |
| Mar 26, 2018(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jan 8, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 18, 2016 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 14, 2016 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jul 24, 2013 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Jul 18, 2013 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |